Technical Analysis for MGNX - MacroGenics, Inc.

Grade Last Price % Change Price Change
grade D 14.32 0.85% 0.12
MGNX closed up 0.85 percent on Wednesday, December 12, 2018, on 1.16 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical MGNX trend table...

Date Alert Name Type % Chg
Dec 12 Spinning Top Other 0.00%
Dec 12 Calm After Storm Range Contraction 0.00%
Dec 12 Narrow Range Bar Range Contraction 0.00%
Dec 12 NR7 Range Contraction 0.00%
Dec 12 Lower Bollinger Band Walk Weakness 0.00%
Dec 12 Inside Day Range Contraction 0.00%
Dec 12 Lower Bollinger Band Touch Weakness 0.00%
Dec 11 Slingshot Bearish Bearish Swing Setup 0.85%
Dec 11 Calm After Storm Range Contraction 0.85%
Dec 11 Lower Bollinger Band Walk Weakness 0.85%

Older signals for MGNX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
MacroGenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases. The company generates its pipeline of product candidates from its proprietary suite of next-generation antibody technology platforms, which it believes improve the performance of monoclonal antibodies and antibody-derived molecules. The company creates both differentiated molecules that are directed to novel cancer targets, as well as "bio-betters," which are drugs designed to improve upon marketed medicines. The combination of MacroGenics' technology platforms and antibody engineering expertise has allowed the company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies.
Is MGNX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 32.74
52 Week Low 11.16
Average Volume 349,571
200-Day Moving Average 21.6176
50-Day Moving Average 17.6246
20-Day Moving Average 16.448
10-Day Moving Average 15.91
Average True Range 1.2863
ADX 19.68
+DI 16.9202
-DI 36.1046
Chandelier Exit (Long, 3 ATRs ) 14.3911
Chandelier Exit (Short, 3 ATRs ) 15.0189
Upper Bollinger Band 18.7118
Lower Bollinger Band 14.1842
Percent B (%b) 0.03
BandWidth 27.526751
MACD Line -0.8265
MACD Signal Line -0.5873
MACD Histogram -0.2392
Fundamentals Value
Market Cap 526.95 Million
Num Shares 36.8 Million
EPS -4.19
Price-to-Earnings (P/E) Ratio -3.42
Price-to-Sales 56.93
Price-to-Book 2.96
PEG Ratio 0.01
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.89
Resistance 3 (R3) 14.88 14.67 14.80
Resistance 2 (R2) 14.67 14.53 14.68 14.76
Resistance 1 (R1) 14.50 14.44 14.59 14.51 14.73
Pivot Point 14.29 14.29 14.34 14.30 14.29
Support 1 (S1) 14.12 14.15 14.21 14.13 13.91
Support 2 (S2) 13.91 14.06 13.92 13.88
Support 3 (S3) 13.74 13.91 13.85
Support 4 (S4) 13.75